Cargando…

Estimation of SARS-CoV-2 IgG Antibodies in Healthcare Worker-Administered Covishield and Covaxin Vaccines at a Tertiary Care Hospital in Jharkhand, India

Introduction To mitigate the impact of the COVID-19 pandemic caused by the SARS-CoV-2 virus, global distribution of vaccines such as Covishield and Covaxin has been undertaken. This research aimed to assess the responses and potential differences between these vaccines by examining the presence and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Singh, Bishnupati, Seema, Kumari, Mahuli, Amit V, Kumar, Abhay, Boipai, Manju, Sharma, Ashok K, Kumar, Manoj, Kumar, Surender, Chandra, Subhash, Shahi, Ajoy K
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Cureus 2023
Materias:	Public Health
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10666192/ https://www.ncbi.nlm.nih.gov/pubmed/38021860 http://dx.doi.org/10.7759/cureus.47566

Ejemplares similares

Emerging threat of candida resistance among neonates at a teaching institute of Jharkhand
por: Biswas, Binita, et al.
Publicado: (2023)

“Covishield and Covaxin” – India's contribution to global COVID-19 pandemic
por: Raina, Sunil Kumar, et al.
Publicado: (2021)

Immunogenic and reactogenic efficacy of Covaxin and Covishield: a comparative review
por: Das, Swarnali, et al.
Publicado: (2022)

P492 Invasive fungal infection during COVID era at tertiary care hospital
por: Seema, Kumari, et al.
Publicado: (2022)

Comparison of in-hospital COVID-19 related outcomes between COVISHIELD and COVAXIN recipients
por: Suri, Tejas M., et al.
Publicado: (2022)

Comparative study between Saliva and Nasopharyngeal & Oropharyngeal Swab Specimens for Detection of SARS -CoV-2 (Novel Corona Virus) by RT-PCR
por: Sharma, Ashok Kumar, et al.
Publicado: (2021)

Adverse effects after first and second dose of covishield and covaxin: A longitudinal study
por: Mittal, Amit, et al.
Publicado: (2022)

Prevalence and pattern of maxillofacial injuries and treatment outcome after bear attacks in Jharkhand population
por: Vishal,, et al.
Publicado: (2022)

2371. A study to describe the pattern of cutaneous adverse effects of COVID-19 vaccines (Covishield and Covaxin )
por: Mitra, Debdeep, et al.
Publicado: (2023)

E-learning during the COVID-19 Pandemic in Various Healthcare Institutes of India
por: Kumar, Surender, et al.
Publicado: (2022)

Effectiveness of Covid-19 vaccines (Covishield(TM) and Covaxin (®)) in healthcare workers in Mumbai, India: A retrospective cohort analysis
por: Contractor, Aashish, et al.
Publicado: (2022)

Polyfunctional CD4 T-cells correlating with neutralising antibody is a hallmark of COVISHIELD(TM) and COVAXIN(®) induced immunity in COVID-19 exposed Indians
por: Rakshit, Srabanti, et al.
Publicado: (2023)

Idiopathic gingival fibromatosis with massive gingival overgrowth: A rare case report
por: Sharma, Swati, et al.
Publicado: (2020)

Anti SARS-CoV 2 IgG antibody response in fully vaccinated Covishield (AZD1222) and Covaxin (BBV-152) recipients: a study done in southern part of West Bengal, India
por: Satpathi, Partha Sarathi, et al.
Publicado: (2022)

Prevalence, severity, and risk factor of breakthrough infection after vaccination with either the Covaxin or the Covishield among healthcare workers: A nationwide cross-sectional study
por: Krishna, Bhavya, et al.
Publicado: (2022)

Effectiveness of BBV152/Covaxin and AZD1222/Covishield vaccines against severe COVID-19 and B.1.617.2/Delta variant in India, 2021: a multi-centric hospital-based case-control study
por: Bhatnagar, Tarun, et al.
Publicado: (2022)

Morphological study of the menisci of the knee joint in human cadaver in Jharkhand population
por: Gupta, Govind Kumar, et al.
Publicado: (2022)

A cross-sectional study of clinical and laboratory characteristics of systemic lupus erythematosus in tribal region of Jharkhand at RIMS, Ranchi
por: Kumar, Ravi, et al.
Publicado: (2022)

Effectiveness of bilastine and fexofenadine among allergic Rhinitis patients in Ranchi, Jharkhand, India
por: Kumari, Abha, et al.
Publicado: (2022)

Prevalence of Oral Submucous Fibrosis, Its Correlation of Clinical Grading to Various Habit Factors among Patients of Bihar: A Cross Sectional Study
por: Rani, Priya, et al.
Publicado: (2023)

A Study on the Clinical Profiles of Patients With Cerebrovascular Accident (Stroke) in a Tertiary Care Hospital in Jharkhand
por: Kumar, Madhusudan, et al.
Publicado: (2023)

Clinical and epidemiological profile of snakebite cases – A study from an industrial teaching hospital at Jamshedpur, Jharkhand, India
por: Satyanarayan, Bhagyalakshmi, et al.
Publicado: (2022)

Cardiovascular Complication following Covishield Vaccination in Nepal: A Case Report
por: Basnet, Angela, et al.
Publicado: (2021)

State of Dental Health and Management Needs of Young Hemophilic Patients: A Case-control Study
por: Sharma, Swati, et al.
Publicado: (2023)

Prime-Boost Vaccination With Covaxin/BBV152 Induces Heightened Systemic Cytokine and Chemokine Responses
por: Kumar, Nathella Pavan, et al.
Publicado: (2021)

Clinical outcomes in individuals hospitalized with SARS-CoV-2 Delta variant (B.1.617.2) who had been vaccinated with Covishield (ChAdOx1) and Covaxin (BBV-152)
por: Munigela, Apoorva, et al.
Publicado: (2022)

Humoral antibody kinetics with ChAdOx1-nCOV (Covishield™) and BBV-152 (Covaxin™) vaccine among Indian Healthcare workers: A 6-month longitudinal cross-sectional Coronavirus Vaccine-induced antibody titre (COVAT) study
por: Singh, Awadhesh Kumar, et al.
Publicado: (2022)

Incidence of Canine Impaction in Tribal Population of Jharkhand
por: Jha, Awanindra K., et al.
Publicado: (2023)

Covaxin-Induced Lymphocytic Myocarditis
por: Mittal, Nitish, et al.
Publicado: (2022)

Knowledge, attitude, and hesitance toward COVID-19 vaccination – a cross-sectional study from Jharkhand
por: Kumari, Anita, et al.
Publicado: (2022)

Antibody response after first and second-dose of ChAdOx1-nCOV (Covishield(TM)®) and BBV-152 (Covaxin(TM)®) among health care workers in India: The final results of cross-sectional coronavirus vaccine-induced antibody titre (COVAT) study
por: Singh, Awadhesh Kumar, et al.
Publicado: (2021)

Impact of prior vaccination with Covishield(TM) and Covaxin® on mortality among symptomatic COVID-19 patients during the second wave of the pandemic in South India during April and May 2021: a cohort study
por: Abhilash, Kundavaram Paul Prabhakar, et al.
Publicado: (2022)

Cross reactivity of Dengue, Scrub typhus and Widal test among COVID-19 positive patients
por: SEEMA, K.U.M.A.R.I., et al.
Publicado: (2021)

Malaria epidemiology in an area of stable transmission in tribal population of Jharkhand, India
por: Das, Manoj K., et al.
Publicado: (2017)

Herpes Zoster Following Covaxin Receipt
por: Muhie, Oumer Abdu, et al.
Publicado: (2021)

Data on periodontal health among elderly people in Bushland, Jharkhand, Magadha and Patna, India
por: Chatterjee, Silpi, et al.
Publicado: (2021)

To Evaluate the Prevalence of Edentulousness, the Present Prosthetic Status, and the Need for Prosthetic Treatment in the Population of Garhwa, Jharkhand
por: Mishra, Amit Kumar, et al.
Publicado: (2021)

To study the effect of ‘Covishield’ vaccination on pre-donation platelet counts of plateletpheresis donors
por: Tomar, Akshaya, et al.
Publicado: (2023)

A Study of the Profile of Scrub Typhus in a Tertiary Care Hospital in Jharkhand: An Underestimated Problem
por: Kamath, Sangita D, et al.
Publicado: (2022)

WCN23-0557 Higher pro-inflammatory cytokines are associated with anti-SARS-CoV-2 spike protein-specific seroconversion after two doses of COVAXIN™, COVISHIELD™ vaccination in renal transplant recipients
por: Prasad, N., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mmkn7rna754ruu8i0ductho1l9